EGFR and breast carcinoma: To further verify the inhibitory effect of EGFR on miR-338-3p, MCF-7 human breast cancer cells and 4T1 cells were transfected with increasing amounts of EGFR (0.5 μg, 1 μg and 1.5 μg).